Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis
Year: 2012
Type: article
Abstract: AIMS: The importance of transforming growth factor beta (TGFβ) as an immune regulatory cytokine in atherosclerosis has been established. However, the role of TGFβ signalling in dendritic cells (DCs) and in DC-mediated T cell proliferation and differentiation in atherosclerosis is unknown. METHODS AND RESULTS: Here, we investigated the effect of disrupted TGFβ signalling in DCs on atherosclerosis by using mice carrying a transgene resulting in functional inactivation of TGFβ receptor II (TGFβRII) signalling in CD11c(+) cells (Apoe(-/-)CD11cDNR). Apoe(-/-)CD11cDNR mice exhibited an over two-fold increase in the plaque area compared with Apoe(-/-) mice. Plaques of Apoe(-/-)CD11cDNR mice showed an increase in CD45(+) leucocyte content, and specifically in CD3(+), CD4(+) and CD8(+) cells, whereas macrophage content was not affected. In lymphoid organs, Apoe(-/-)CD11cDNR mice had equal amounts of CD11c(+) cells, and CD11c(+)CD8(+) and CD11c(+)CD8(-) subsets, but showed a subtle shift in the CD11c(+)CD8(-) population towards the more inflammatory CD11c(+)CD8(-)CD4(-) DC subset. In addition, the number of plasmacytoid-DCs decreased. Maturation markers such as MHCII, CD86 and CD40 on CD11c(hi) cells did not change, but the CD11cDNR DCs produced more TNFα and IL-12. CD11c(+) cells from CD11cDNR mice strongly induced T-cell proliferation and activation, resulting in increased amounts of effector T cells producing high amounts of Th1 (IFN-γ), Th2 (IL-4, IL-10), Th17 (IL-17), and Treg (IL-10) cytokines. CONCLUSION: Here, we show that loss of TGFβRII signalling in CD11c(+) cells induces subtle changes in DC subsets, which provoke uncontrolled T cell activation and maturation. This results in increased atherosclerosis and an inflammatory plaque phenotype during hypercholesterolaemia.
Source: European Heart Journal
Authors: Dirk Lievens, Kim L. Habets, Anna-Karin Robertson, Yasmina Laouar, Holger Winkels, Timo Rademakers, Linda Beckers, Erwin Wijnands, Louis Boon, Munir Mosaheb, Hafid Ait-Oufella, Ziad Mallat, Richard A. Flavell, Mats Rudling, Christoph J. Binder, Norbert Gerdes, Erik A.L. Biessen, Christian Weber, Mat J.A.P. Daemen, Johan Kuiper, Esther Lutgens
Institutions: Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universität München, Leiden University, Howard Hughes Medical Institute, Yale University, Maastricht University, Polpharma Biologics (Netherlands), Inserm, Paris Cardiovascular Research Center, Université Paris Descartes, University of Cambridge, Addenbrooke's Hospital, Karolinska University Hospital, Karolinska Institutet, Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Amsterdam UMC Location University of Amsterdam, University of Amsterdam
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: British Heart Foundation
OpenAlex ID: W2135680346